【涉嫌违规推广处方药 诺和诺德(NVO.US)遭西班牙卫生部调查】智通财经APP获悉,西班牙卫生部正在调查畅销减肥药We

智通财经
25 Jun
【涉嫌违规推广处方药 诺和诺德(NVO.US)遭西班牙卫生部调查】智通财经APP获悉,西班牙卫生部正在调查畅销减肥药Wegovy的开发商诺和诺德(NVO.US)是否违反了禁止推广处方药的广告法律。根据西班牙卫生部上周发布的一份声明,诺和诺德被要求提供有关其在线肥胖意识宣传活动中获得科学协会背书的相关文件。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10